BLUFFTON, S.C. (WSAV) – It’s the most common cancer among men. More than 300,000 new cases every year in the United States alone. But most men still don’t know much about prostate cancer. About one in ...

Prostate cancer relies on genetic "switches," called enhancers, that can turn on tumor-promoting genes. Researchers at the ...

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment. It is important to target intensified therapy ...

Biden's diagnosis raises questions about prostate cancer. Experts answer listener questions and conc President Joe Biden's cancer diagnosis has sparked a wave of concern, as well as questions about ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes.Researchers at the University of Michigan ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with prostate cancer during his lifetime, if you are experiencing symptoms, it ...

Veteran journalist Rajdeep Sardesai has revealed his battle with prostate cancer and shared that he underwent successful robotic surgery. His story highlights the importance of regular health checkups ...

Scientists have identified two enzymes that help prostate cancer cells grow, survive and resist treatment, paving the way for new treatments.

CHICAGO — Addressing a packed hall here at the American Society of Clinical Oncology (ASCO) 2018 annual meeting, the president of ASCO drew long-standing applause after he described the new ...